Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Vimpat 100mg tablets
0408010AHBBABAB
|
Vimpat | Lacosamide | Central Nervous System | 1,209 |
|
Vimpat 200mg tablets
0408010AHBBADAD
|
Vimpat | Lacosamide | Central Nervous System | 1,101 |
|
Vimpat 50mg tablets
0408010AHBBAAAA
|
Vimpat | Lacosamide | Central Nervous System | 899 |
|
Vimpat 150mg tablets
0408010AHBBACAC
|
Vimpat | Lacosamide | Central Nervous System | 497 |
|
Vimpat 10mg/ml syrup (USB Pharma)
0408010AHBBAHAG
|
Vimpat | Lacosamide | Central Nervous System | 398 |
|
Vimpat 10mg/ml syrup (Imported)
0408010AHBBAGAG
|
Vimpat | Lacosamide | Central Nervous System | No data available |
|
Vimpat 15mg/ml syrup
0408010AHBBAFAF
|
Vimpat | Lacosamide | Central Nervous System | No data available |
|
Vimpat 200mg/20ml solution for infusion vials
0408010AHBBAEAE
|
Vimpat | Lacosamide | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.